Retina

Dr Uwe Oberheide discusses the key findings of his virtual ARVO 2021 presentation on modelling of IOLs for patients with AMD by ray tracing.

At ARVO’s 2021 virtual annual meeting, John Wells, MD, presents efficacy, durability, and safety findings from the phase 3 YOSEMITE and RHINE trials.

Uwe Oberheide, MD, discusses the key findings of his virtual ARVO 2021 presentation on modeling of IOLs for patients with AMD by ray-tracing.

Preexisting neutralizing antibodies associated with the inflammatory changes.

Study evaluates the impact of surgical procedure on visual outcomes in patients

Fluocinolone acetonide implant for DME benefits visual acuity.

Injections, implants continue to create further positive outcomes for patients.

In a real-world study of patients with treatment-naïve and previously treated diabetic macular oedema, injection of intravitreal dexamethasone 0.7-mg implant provided effective disease control with initial and repeat injections, regardless of reinjection interval.

Eyes with chronic disease responded to steroid treatment.

Topical eye drop treatments for the posterior segment would offer easier, less invasive options than those currently available. This would reduce the burden on both patients and their caregivers, increasing adherence and improving outcomes.

Studying zebrafish helps unravel mysteries of photoreceptor regeneration .

‘Revolutionary Eye and Vision Research’ theme of annual meeting.

Studies are uncovering a range of potential treatment options for disorders.

Options for physicians are increasing in availability with fewer burdens for patients.

Minimizing clinic visits, maximizing use of imaging modalities are key.

Physician offers patient counseling pearls for selected retinal diseases.

During the trial, a patient gained vision, which lasted more than a year, after a single injection of an experimental RNA therapy into the eye.

Mary Elizabeth Hartnett, MD, FACS, FARVO, and Mark Breazzano, MD, discuss current research being conducted involving AMD and maximizing patient outcomes amid the pandemic.

Study highlights role of demographic and socioeconomic characteristics in treatment.

The results from Diabetic Retinopathy Clinical Research Network protocols have become the standard of care for treating DME and proliferative diabetic retinopathy.

Option demonstrates stable to improved visual acuity and retinal thickness.

Rapid fluid identification may result in better visual outcomes.

En-face OCT has advantages that make it very useful for characterising macular anatomy and pathologic features of various macular disorders.

Transient sensory-motor abnormalities are often common